Adenovirus-mediated gene therapy of osteoblasts in vitro and in vivo

Journal of Bone and Mineral Research

Volumn 14, Issue 8, 1999, Pages 1290-1301

  Mehrara, Babak J ^a   Saadeh, Pierre B ^a   Steinbrech, Douglas S ^a   Dudziak, Matthew ^a   Spector, Jason A ^a   Greenwald, Joshua A ^a   Gittes, George K ^a   Longaker, Michael T ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; COLLAGEN TYPE 1; MESSENGER RNA; RECOMBINANT PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN; VIRUS VECTOR;

ADENOVIRUS; AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIAL GENETICS; BONE DEVELOPMENT; BONE REGENERATION; CALCIFICATION; CELL PROLIFERATION; CONTROLLED STUDY; EPIPHYSIS PLATE; ESCHERICHIA COLI; FRACTURE HEALING; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; GENETIC TRANSFECTION; HUMERUS; NONHUMAN; OSTEOBLAST; RAT; RECEPTOR UPREGULATION;

ADENOVIRIDAE; BETA-GALACTOSIDASE; BONE REGENERATION; CELLS, CULTURED; ENDOTHELIAL GROWTH FACTORS; FRACTURE HEALING; GENE THERAPY; GENETIC VECTORS; HUMANS; LAC OPERON; LYMPHOKINES; OSTEOBLASTS; OSTEOGENESIS; POLYMERASE CHAIN REACTION; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0032772690     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.1999.14.8.1290     Document Type: Article

References (61)

1. Beck LS, Amanto EP, Xu Y, Deguzman L, Lee WP, Nguyen T, Gilett NA 1993 TGF beta 1 induces bone closure of skull defects: Temporal dynamics of bone formation in defects exposed to rhTGF-B1. J Bone Miner Res 8:753-761.
2. Lindholm TC, Lindhold TS, Martinen A, Urist MR 1994 Bone morphogenetic protein (bBMP/NCP) induced repair of skull trephine defects in pigs. Clin Orthop 30:263-270.
3. Linkhart TA, Mohan S, Baylink DJ 1996 Growth factors for bone growth and repair: IGF, TGF-B, and BMP. Bone 19:1S.
4. Centrella M, McCarthy TL, Canalis E 1987 Transforming growth factor beta is a bifunctional regulator of replication and collagen synthesis in osteoblast-enriched cell cultures from fetal rat bone. J Biol Chem 262:2869-2874.
5. Lind M, Schumacker B, Soballe K, Keller J, Melson F, Bunger C 1993 Transforming growth factor B enhances fracture healing in rabbit tibiae. Acta Orthop Scand 64:553-556.
6. Joyce ME, Jirgushi S, Bolander ME 1990 Transforming growth factor B in the regulation of fracture repair. Orthop Clin North Am 21:199-209.
7. Robey PG, Young MF, Flanders KC, et al. 1987 Osteoblasts synthesize and respond to Transforming Growth Factor-Type B (TGF-B) in vitro. J Cell Biol 106:457-463.
8. Thorp BH, Anderson I, Jakowlew SB 1992 Transforming growth factor-B1, B2, and B3 in cartilage and bone cells during endochondral ossification in the chick. Development 114:907-911.
9. Datta H, Zaidi M, Jayant B, Champaneri B, MacIntyre I 1989 Transforming growth factor-B induced mitogenesis of human bone cancer cells. Biochem Biophys Res Commun 161:672-676.
10. DeLustro F, Dasch J, Keefe J, Ellingsworth L 1990 Immune responses to allogeneic and xenogeneic implants of collagen and collagen derivatives. Clin Orthop 260:263-279.
11. Ongpipattanakul B, Nguyen T, Zioncheck T, Wong R, Osaka G, DeGuzman L, Lee W, Beck L 1997 Development of tricalcium phosphate/amylopectin paste combined with recombinant human transforming growth factor beta 1 as a bone defect filler. J Biomed Mater Res 36:295-305.
12. Gombotz W, Pettit D 1995 Biodegradable polymers for protein and peptide drug delivery. Bioconjug Chem 6:332-351.
13. Langer R, Moses M 1991 Biocompatible controlled release polymers for delivery of polypeptides and growth factors. J Cell Biochem 45:340-345.
14. Schmitt E, Flanagan D, Linhardt R 1993 Degradation and release properties of pellets fabricated from three commercial poly(D,L-lactide-co-glycolide) biodegradable polymers. J Pharm Sci 82:326-329.
15. Kovesdi I, Brough DE, Bruder JT, Wickham TJ 1997 Adenoviral vectors for gene transfer. Curr Opin Biotechnol 8:583-589.
16. Grunhaus A, Horwitz MS 1992 Adenoviruses as cloning vectors. Virology 3:237-252.
17. Graham F, Prevec L 1995 Methods for construction of adenovirus vectors. Mol Biotech 3:207-220.
18. Owen TA, Bortell R, Yocum SA, Smock SL, Zhang M, Abate C, Shalhoub V, Aronin N, Wright KL, van Wijnen, et al. 1990 Coordinate occupancy of AP-1 sites in the vitamin D-responsive and CCAAT box elements of Fos-Jun in the osteocalcin gene: Model for phenotype suppression of transcription. Proc Natl Acad Sci USA 87:9990-9994.
19. Mehrara BJ, Rowe NM, Steinbrech DS, Dudziak ME, Saadeh PB, McCarthy JG, Gittes GK, Longaker MT 1998 Rat mandibular distraction osteogenesis part II: Molecular analysis of Transforming Growth Factor Beta-1 and Osteocalcin gene expression. Plast Reconstr Surg 103:536-547.
20. Rowe NM, Mehrara BJ, Dudziak ME, Steinbreck DS, Saadeh PB, MacKool RJ, Gittes GK, McCarthy JG, Longaker MT 1997 Rat mandibular distraction osteogenesis: Part I. Histologic and molecular analysis. (Submitted for publication).
21. Kueng W, Silber E, Eppenberger U 1989 Quantification of cells cultured on 96-well plates. Anal Biochem 182:16-19.
22. Harris SE, Bonewald CF, Sabatini M, Dallas S, Feng JQ, Ghosh-Choudury N, Wozney J, Muncy GR 1994 Effects of transforming growth factor beta on bone nodule formation and expression of bone morphogenetic protein 2, osteocalcin, osteopontin, alkaline phosphatase, and type I collagen mRNA in long term cultures of fetal rat calvarial osteoblasts. J Bone Miner Res 9:855-863.
23. Hiltunen A, Hannu TA, Vuorio E 1993 Regulation of extra-cellular matrix genes during fracture healing. Clin Orthop 297:23-27.
24. Ritzenthaler J, Goldstein R, Fine A, Lichtler A, Rowe D, Smith B 1991 Transforming growth factor beta activation elements in the distal promoter regions of the rat alpha 1 type 1 collagen gene. Biochem J 280:157-162.
25. Rossi P, Karsenty G, Roberts A, Roche N, Sporn M, de Crombrugghe B 1988 A nuclear factor 1 binding site mediates the transcriptional activation of a type 1 collagen promoter by transforming growth factor beta. Cell 52:405-414.
26. Chung K, Agarwal A, Uitto J, Mauviel A 1996 An AP-1 binding sequence is essential for regulation of the human alpha2(I) collagen (Col1A2) promoter activity by transforming growth factor-beta. J Biol Chem 271:3272-3278.
27. Webb K, Henney A, Anglin S, Humphries S, McEwan J 1997 Expression of matrix metalloproteinases and their inhibitor TIMP-1 in the rat carotid artery after balloon injury. Arterioscler Thromb Vasc Biol 17:1837-1844.
28. Ferrara N, Davis-Smyth T 1997 The Biology of vascular endothelial growth factor. Endocr Rev 18:4-25.
29. Massague J 1990 The transforming growth factor-B family. Annu Rev Cell Biol 6:597-641.
30. Massague J 1996 TGFB signaling: Receptors, transducers, and Mad proteins. Cell 85:947-950.
31. Dallas S, Miyazono K, Skerry T, Mundy G, Bonewald L 1995 Dual role for the latent transforming growth factor-B binding protein in storage of latent TGF-B in the extracellular matrix and as a structural matrix protein. J Cell Biol 131:539-549.
32. Centrella M, Horowitz M, Wozney J, McCarthy T 1994 Transforming growth factor-B gene family members and bone. Endocr Rev 15:27-39.
33. Bonewald L, Wakefield L, Oreffo R, Escobedo A, Twsrdzik D, Mundy G 1991 Latent forms of transforming growth factor B (TGF-B) derived from bone cultures: Identification of a naturally occurring 100-KDa complex with similarity to recombinant latent TGF-B. Mol Endocrinol 5:741-751.
34. Nilsen-Hamilton M 1990 Transforming growth factor-beta and its actions on cellular growth and differentiation. Curr Top Dev Biol 24:95-136.
35. Wrana JL, Attisano L, Weiser R, Ventrua F, Massague J 1994 Mechanisms of activation of the TGF-B receptor. Nature 370:341-347.
36. Wieser R, Wrana JL, Massague J 1995 GS domain mutations that constitutively activate TBR-I, the downstream signaling component in the TGF-B receptor complex. EMBO J 14:2199-2208.
37. Nakao A, Imamura T, Souchelnytskyi S, Kawabata M, Ishisaki A, Oeda E, Tamaki K, Hanai J, Heldin CH, Miyazono K, ten Dijke P 1997 TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4. EMBO J 16:5353-5362.
38. Mucsi I, Howard J, Goldberg HJ 1997 Dominant-negative? SMAD-3 interferes with transcriptional activation by multiple agonists. Biochem Biophys Res Commun 232:517-521.
39. 3 in mouse long bones: Interaction with the bone-derived growth factors TGF-B and IGF-I. J Bone Miner Res 13:36-43.
40. Heldin CH, Miyazono K, ten Dijke P 1997 TGF-beta signaling from cell membrane to nucleus through SMAD proteins. Nature 390:465-471.
41. Flanders K, Holder M, Winokur T 1995 Auto-induction of mRNA and protein expression for transforming growth factor-beta in cultured cardiac cells. J Mol Cell Cardiol 27:805-812.
42. Kelley J, Shull S, Walsh J, Cutroneo K, Absher M 1993 Auto-induction of transforming growth factor-beta in human lung fibroblasts. Am J Respir Cell Mol Biol 8:417-424.
43. Norgaard P, Spang-Thomsen M, Poulsen HS 1996 Expression and autoregulation of transforming growth factor beta receptor mRNA in small-cell lung cancer cell lines. Br J Cancer 73:1037-1043.
44. Woodward T, Dumont N, O'Connor-McCourt M, Turner J, Philip A 1995 Characterization of transforming growth factor-beta growth regulatory effects and receptors on bovine mammary cells. J Cell Phys 165:339-348.
45. Nakao A, Afrakhte M, Moren A, Nakayama T, Christian JL, Heuchel R, Itoh S, Kawabata M, Heldin NE, Heldin CH, ten Dijke P 1997 Identification of Smad7, a TGF-beta-inducible antagonist of TGF-beta signaling. Nature 389:631-635.
46. Whitman M 1997 Signal transduction: Feedback from inhibitory SMADs. Nature 389:549-551.
47. Graham C 1997 Effect of transforming growth factor-beta on the plasminogen activator system in cultured first trimester human cytotrophoblasts. Placenta 18:137-143.
48. Campbell I, Wojta J, Novak U, Hamilton J 1994 Cytokine modulation of plasminogen activator inhibitor-1 (PAI-1) production by human articular cartilage and chondrocytes: Down-regulation by tumor necrosis factor alpha and up-regulation by transforming growth factor-B basic fibroblast growth factor. Biochim Biophys Acta 1226:277-285.
49. Joyce ME, Roberts A, Sporn MB, Bolander ME 1990 Transforming growth factor-B in the initiation of chondrogenesis and osteogenesis in the rat femur. J Cell Biol 110:2195-2207.
50. Hughes F, Aubin J, Heersche J 1992 Differential chemotactic responses of different populations of fetal rat calvaria cells to platelet-derived growth factor and transforming growth factor B. Bone Miner 19:63-74.
51. Hanazawa S, Takeshita A, Tsukamoto Y, Kawata Y, Takara K, Kitano S 1991 Transforming growth factor-B induced gene expression of monocyte chemoattractant JE in mouse osteoblastic cells, MC3T3-E1. Biochem Biophys Res Commun 180:1130-1136.
52. Pfeilshifter J, Wolf O, Nauman A, Minne H, Mundy G, Ziegler R 1990 Chemotactic response of osteoblast-like cells to transforming growth factor B. J Bone Miner Res 5:825-830.
53. Lucas P, Caplan A 1983 Chemotactic response of embryonic limb bud mesenchymal cells and muscle derived fibroblasts to transforming growth factor B. Connect Tissue Res 18:1-7.
54. Globus RK, Patterson-Buckendahl P, Gospodarowicz D 1988 Regulation of bovine bone cell proliferation by fibroblast growth factor and transforming growth factor B. Endocrinology 123:98-105.
55. Macnab I, DeHass WC 1974 The role of the periosteal blood supply in the healing of fractures of the tibia. Clin Orthop 105:27-33.
56. Grundes O, Reikeras O 1992 Blood flow and mechanical properties of healing bone: Femoral osteotomies studied in rats. Acta Orthop Scand 63:487-491.
57. Pertovaara L, Saksela O, Alitalo K 1993 Enhanced bFGF gene expression in response to transforming growth factor-B stimulation of AKR-2B cells. Growth Factors 9:81-86.
58. Pertovarra L, Kaipainen A, Mustonen T, Orpana A, Ferrara N, Saksela O, Alitalo K 1994 Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells. J Biol Chem 269:6271-6274.
59. Koochenkpour S, Merzak A, Pilkington C 1996 Vascular endothelial growth factor production is stimulated by gangliosides and TGF-beta isoforms in human glioma cells in vitro. Cancer Lett 102:209-215.
60. Donovan D, Harmey J, Toomey D, Osborne D, Redmond H, Bouchier-Hayes D 1997 TGF beta-1 regulation of VEGF production by breast cancer cells. Ann Surg Oncol 4:621-627.
61. Brogi E, Wu T, Namiki A, Isner J 1994 Indirect angiogenic cytokines up-regulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. Circulation 90:649-652.